Rao Raghu 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Oct 27, 2023
Insider Transaction Report
Form 4
Rao Raghu
DirectorInterim CEO
Transactions
- Purchase
Common Stock
2023-10-27+15,625→ 16,813 total - Purchase
Warrant to Purchase Common Stock
2023-10-27+31,250→ 31,250 totalExercise: $1.60From: 2023-10-27Exp: 2028-10-27→ Common Stock (31,250 underlying)
Footnotes (3)
- [F1]Reporting Person purchased 15,625 shares of common stock and 31,250 warrants to purchase 31,250 shares of common stock pursuant to an underwritten public offering by the Issuer at $1.60 per share and accompanying two warrants. The offering closed on October 27, 2023.
- [F2]Includes unvested RSUs.
- [F3]All amounts reflect the 1:22 reverse stock split effective as of August 31, 2023.